Dr. Sahoo at 14th Biosimilars Congregation in Mumbai

Among the discussed topics of the 14th Biosimilars Congregation in Mumbai were the regulatory updates, present state of the biosimilars market, product development strategies, challenges, and many more. Dr. Umakanta Sahoo, GCT Managing Director in India was there to examine the latest trends in the biosimilars drug development field together with the industry experts. The meeting was truly insightful and turned into a major international networking platform.

Updated: December 17, 2019

Permanent link: https://2022.gctrials.com/posts/dr-sahoo-at-14th-biosimilars-congregation-in-mumbai/

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

About

GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login

 

GCT

© 2001—2021 Global Clinical Trials, LLC

All rights reserved.